Vertex Pharmaceuticals EVP and CMO Carmen Bozic sold 2,329 shares of Vertex common stock at an average price of $480.31 per share on February 27, 2026. This transaction was conducted under a pre-established Rule 10b5-1 trading plan initiated on November 20, 2025. Following the sale, Bozic directly owns 37,734 shares of the company.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Vertex (VRTX) CMO Carmen Bozic executes Rule 10b5-1 sale of 2,329 shares
Vertex Pharmaceuticals EVP and CMO Carmen Bozic sold 2,329 shares of Vertex common stock at an average price of $480.31 per share on February 27, 2026. This transaction was conducted under a pre-established Rule 10b5-1 trading plan initiated on November 20, 2025. Following the sale, Bozic directly owns 37,734 shares of the company.